Navigation Links
Epidural Mistakes Proves To Be Fatal Blunders

Epidurals are usually given during childbirth to ease the pain during labor. But such epidurals proved to be fatal due to hospital blunders //. The National Patient Safety Agency (NPSA) in response has issued warnings to doctors and midwives over the drug usage. Statistics show that about 200 errors have been committed due a period of one year.

The epidural is supposed to be administered at the base of the spine, but in some cases they have been accidentally injected into veins in their arms which results in a heart attack. The main reason behind accidental injection is that staffs confuse bags containing the epidural with other drugs. In case of pregnant women epidurals are given for pain relief during labor. Intravenous drips are also given to speed up contractions and maintain blood pressure. But these two drugs get muddled up resulting in a lot of confusion. Professor David Cousins, head of safe medication practice said that NPSA would take all necessary action to prevent wrong-route errors.

When the doctors and nurses were asked to monitor such mishaps it was found that in a number of cases the drug bupivacaine, a local anaesthetic used in epidurals, being administered into the veins. Dr Maggie Blott, a consultant obstetrician at Royal Victoria Infirmary, Newcastle upon Tyne, said that this figure of mistakes prove that midwives are not getting the right training. Sometimes these mistakes result in fatal blunders such as the case of Mayra Cabrera. She was admitted in the Great Western hospital in Swindon, Wiltshire. She is a theatre nurse and was aged 30 but died after giving birth to her son due to accidentally injection of the epidural into her arm.


'"/>




Page: 1

Related medicine news :

1. Epidural given in early labor may not lead to caesarian birth
2. Epidural can affect the fetal head position
3. Epidurals Associated With Breastfeeding Problems
4. Epidural Steroid Injections Do Not Provide Long Term Relief
5. Learning to Prevent Medical Mistakes in Caring for Stroke Patients
6. ZD1839 Proves Effective - A Breakthrough in fighting Lung Cancer
7. Study Proves That MMR Vaccine Is Not Connected To Autistic Babies
8. Pilot Study Proves Home Abortions ‘Safe’
9. Many Nonprescription Cough Medicines Proves Ineffective
10. Less Invasive By Pass Surgery Proves Economical In The Long Run
11. Combined Anti-Fever Drug Therapy Proves Unsafe for Childhood Fever
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/20/2017)... ... ... “They Sang At Her Funeral”: a tale of murder that will bring ... their closets. “They Sang At Her Funeral” is the creation of published author, Annalise ... five children and twelve grandchildren. Before becoming a writer, Annalise had the opportunity to ...
(Date:9/19/2017)... ... 2017 , ... Only a few physicians were selected to receive the prestigious ... Clevens, MD, FACS . The founder and medical director of Clevens Face and ... at Yale, Harvard and the University of Michigan. He has served patients throughout Central ...
(Date:9/19/2017)... ... , ... Trusted debt-reduction firm CreditAssociates, LLC has announced two important milestones. To ... $835 million in resolved debt for its clients. , Credit card debt, unpaid hospital ... of debt settled by the company. With more than a decade of combined service ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... to funding innovative lymphoma research and serving the lymphoma community through a comprehensive ... Texas as a part of its national Swirl: A Wine Tasting Event series ...
(Date:9/19/2017)... ... September 19, 2017 , ... MelaKids, a Laredo-based company, has ... filter. When we’re born, Nature gives us a full supply of melanin – ... we continuously lose this natural glare-reducing pigment; however, around the age of thirty, we ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... , Sept. 6, 2017  Medical ... knowledge and skills while treating their patients. ... hands-on experience without involving patients. Simulation provides ... Clinicians can carry out procedures, refine techniques ... risk. Integration of new technology, such as ...
(Date:9/6/2017)... -- Eli Lilly and Company (NYSE: LLY ... galcanezumab and lasmiditan, two investigational treatments for migraine, at ... taking place Sept. 7-10 in Vancouver ... data from an open-label study evaluating the safety and ... 240 mg) for the prevention of migraine. Galcanezumab is ...
(Date:9/5/2017)... Sept. 5, 2017  Getinge, a leading global ... vibrant charitable donation program -- "Color for the ... heart defect research by The Children,s Heart Foundation. ... general public are encouraged to download a coloring ... completed artwork to the gallery on the website. ...
Breaking Medicine Technology: